Small Molecules News and Research

RSS

New approach helps immune cells find and attack solid tumors

A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered immunotherapy for solid tumors, according to a new study by Stanford Medicine researchers.

24 Mar 2026

Study reveals new dual role of ezrin in osteosarcoma

Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a well-known cancer-related protein called ezrin.

17 Mar 2026

Innovative microscopic capsules overcome long-standing limitations in single-cell research

Researchers have developed a capsule-based method that makes it possible to analyse the same cell through multiple experimental steps.

12 Mar 2026

Researchers develop non-hormonal contraceptives to reduce side effects for couples

In the 1970s, the contraceptive pill was the most frequently used method of contraception in Western countries; in Germany, for example, one in three women used "the pill."

6 Mar 2026

How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?

A comprehensive Lancet review synthesizes evidence from major clinical trials showing that GLP-1 receptor agonists and next-generation incretin therapies deliver substantial weight loss while reducing cardiovascular and kidney risks. Emerging dual, triple, and oral agents may further expand treatment options and improve outcomes across obesity, type 2 diabetes, and related metabolic diseases.

3 Mar 2026

Tiny protein region unlocks secrets to healthy heartbeat

A tiny region in a little-known muscle protein may hold the key to a healthy, steady heartbeat, as well as possible clues to future treatment of devastating heart ailments.

26 Feb 2026

Phase 2 clinical trial tests LMP744 for the treatment of first-time recurrent glioblastoma

Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent glioblastoma patients.

25 Feb 2026

Metabolite-driven AI model accurately estimates time of death

Artificial intelligence can be used to provide a more precise time of death, which can be crucial in e.g. murder investigations.

24 Feb 2026

Throwing cancer-driving proteins in the cellular trash

When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don't fight them - throw them in the cellular trash.

24 Feb 2026

New technique synthesizes non-natural amino acids for advanced peptide therapeutics

Ozempic has been making headlines for its remarkable success in treating obesity and diabetes. Yet it is just one in a rapidly growing class of drugs called peptide therapeutics that sits between small molecules (like aspirin) and biologics (like antibodies).

20 Feb 2026

Insilico Medicine and MSK collaborate to discover new drug targets for gastroesophageal malignancies

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and Memorial Sloan Kettering Cancer Center (MSK) have entered into a collaborative research agreement aimed at discovering new therapeutic targets for gastroesophageal malignancies.

17 Feb 2026

Calibr-Skaggs and Kainomyx join forces to accelerate development of antimalarial drugs

The Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc., today announced a new research collaboration to accelerate the discovery and development of next-generation antimalarial drugs.

17 Feb 2026

Magnesium lower fasting blood sugar in older adults

Magnesium boosts fasting glucose control in older adults with deficiency, but preventing diabetes progression may need more than just mineral correction.

13 Feb 2026

Researchers identify a previously unknown cellular barrier in the brain

VIB and Ghent University researchers have identified and characterized a previously unknown cellular barrier in the brain, which sheds new light on how the brain is protected from the rest of the body.

12 Feb 2026

Nanovaccine design boosts immune attack on HPV tumors

Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure.

11 Feb 2026

Carterra launches industry’s first 48-channel HT-SPR platform for advanced label-free biomolecular screening and characterization

Carterra Inc., the leading provider of technologies enabling high-throughput biology, today announced the launch of the Carterra Vega™ High-Throughput Surface Plasmon Resonance (HT-SPR) instrument.

From Carterra Inc. 11 Feb 2026

Small Molecules News and Research

New approach helps immune cells find and attack solid tumors

Study reveals new dual role of ezrin in osteosarcoma

Innovative microscopic capsules overcome long-standing limitations in single-cell research

Researchers develop non-hormonal contraceptives to reduce side effects for couples

How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?

Tiny protein region unlocks secrets to healthy heartbeat

Phase 2 clinical trial tests LMP744 for the treatment of first-time recurrent glioblastoma

Metabolite-driven AI model accurately estimates time of death

Throwing cancer-driving proteins in the cellular trash

New technique synthesizes non-natural amino acids for advanced peptide therapeutics

Insilico Medicine and MSK collaborate to discover new drug targets for gastroesophageal malignancies

Calibr-Skaggs and Kainomyx join forces to accelerate development of antimalarial drugs

Magnesium lower fasting blood sugar in older adults

Researchers identify a previously unknown cellular barrier in the brain

Nanovaccine design boosts immune attack on HPV tumors

Carterra launches industry’s first 48-channel HT-SPR platform for advanced label-free biomolecular screening and characterization

Early biomarkers predict infections after breast reconstruction surgery

CDD European Life Science Community Meeting

Gut microbiome may be a central player in the body's response to cancer

Exploring Targeted Protein Degradation as a New Strategy to Tackle Antimicrobial Resistance

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News